Error: Could not add to watchlist. X

Geron Corp

+ Watchlist
GERN:GR
Frankfurt
3.75
EUR
0.02
0.43%
As of 14:19:03 ET on 07/07/2015.
Open
3.91
Day Range
3.75 - 3.95
Volume
1,994
Previous Close
3.76
52Wk Range
1.39 - 4.21
1 Yr Return
70.18%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (m EUR)
592.038
Shares Outstanding (m)
158.088
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Geron Corporation is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
ADDRESS
230 Consititution Drive
Menlo Park, CA 94025
United States
PHONE
1-650-473-7700
  • Huh Hoyoung
    Chairman
  • John A Scarlett
    President/CEO
  • Stephen N Rosenfield
    Exec VP/Secretary/General Counsel
  • Melissa A Kelly Behrs
    Exec VP:Business Development
  • Andrew J Grethlein "Andy"
    Exec VP:Dev & Tech Operations
Show More